Diakron Pharmaceuticals News
Most Popular Diakron Pharmaceuticals Story
Diakron in-licenses program, finds partner
Diakron Pharmaceuticals has simultaneously struck a pair of deals to in-license a Phase I oral anti-coagulant therapy from Merck while signing India's Orchid Chemicals as a development partner for... Read more...
Latest Headlines
- August 13, 2008
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
